Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

ESLA

Estrella Immunopharma Inc

May 13 • 03:36PM ET

1.17

-0.04 -2.89 %

Healthcare • Biotechnology • USA • Micro • NASD

Peers: CUE BLRX INAB NVCT IMNN

| Held by: VTI VXF IWC

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.36	Insider Own	60.61%	Shs Outstand	37.97M	Perf Week	-9.62%
Market Cap	50.13M	Forward P/E	-	EPS next Y	-	Insider Trans	0.01%	Shs Float	16.81M	Perf Month	-30.88%
Enterprise Value	48.75M	PEG	-	EPS next Q	-	Inst Own	3.11%	Short Float	0.88%	Perf Quarter	-9.62%
Income	-13.06M	P/S	-	EPS this Y	-	Inst Trans	1.28%	Short Ratio	1.66	Perf Half Y	-55.66%
Sales	0.00M	P/B	-	EPS next Y	-	ROA	-413.55%	Short Interest	0.15M	Perf YTD	-24.68%
Book/sh	-0.27	P/C	36.32	EPS next 5Y	-	ROE	-314.60%	52W High	3.15 -62.70%	Perf Year	14.07%
Cash/sh	0.03	P/FCF	-	EPS past 3/5Y	-27.10% -70.08%	ROIC	-	52W Low	0.78 50.64%	Perf 3Y	-89.22%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	6.17% 9.79%	Perf 5Y	-
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	-46.67%	Oper. Margin	-	ATR (14)	0.15	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	0.12	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	35.69	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	0.12	EPS Q/Q	44.14%	SMA20	-23.23%	Beta	0.94	Target Price	12.00
Payout	-	Debt/Eq	-	Sales Q/Q	-	SMA50	-14.32%	Rel Volume	0.25	Prev Close	1.21
Employees	-	LT Debt/Eq	-	Earnings	Feb 25	SMA200	-16.84%	Avg Volume	88.67K	Price	1.17
IPO	Sep 14, 2021	Option/Short	No / Yes	EPS/Sales Surpr.	22.22% -	Trades		Volume	20,930	Change	-2.89%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)